Prior Bad Conduct By Pharma Companies Could Be ‘Plus Factor’ In Merger Review

 
• By Brenda Sandburg
  
M&A image
Past anticompetitive behaviour of pharma companies could influence FTC merger analysis • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Compliance

More from Pink Sheet